Associate Professor of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Dr. Gill obtained his medical degree and Ph.D in immunology from the University of Melbourne, and trained in hematology at St Vincent’s Hospital, the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. In 2008 he moved to the United States, first to pursue a post-doctoral fellowship in cellular therapy at Stanford University, and then in 2011 to the University of Pennsylvania where he is now an associate professor of medicine. Dr Gill is also the Scientific Director of Penn’s Center for Cell Therapy and Transplantation, and a co-director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania.
Dr. Gill’s clinical practice is in leukaemia and bone marrow transplantation. He has led clinical trials of chimeric antigen receptor (CAR) T cells for chronic and acute leukemias. Dr. Gill’s research laboratory focuses on the interface between adoptive cellular therapy and genetic engineering, with a strong translational focus.
Disclosure information not submitted.
CAR-T Therapy. Physicians’ Insights and Challenges
Wednesday, July 16, 2025
4:35 PM - 5:15 PM EDT
